VILLANO, GIANMARCO
 Distribuzione geografica
Continente #
NA - Nord America 2.469
AS - Asia 448
EU - Europa 424
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.342
Nazione #
US - Stati Uniti d'America 2.467
CN - Cina 277
IT - Italia 154
SG - Singapore 135
FI - Finlandia 67
SE - Svezia 55
DE - Germania 46
RU - Federazione Russa 25
GB - Regno Unito 22
FR - Francia 20
IN - India 16
UA - Ucraina 15
HK - Hong Kong 9
IE - Irlanda 6
NL - Olanda 6
BG - Bulgaria 3
JP - Giappone 3
KR - Corea 2
TH - Thailandia 2
BD - Bangladesh 1
CA - Canada 1
ES - Italia 1
EU - Europa 1
HU - Ungheria 1
JO - Giordania 1
MX - Messico 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
VN - Vietnam 1
Totale 3.342
Città #
Fairfield 325
Chandler 252
Woodbridge 218
Ann Arbor 189
Wilmington 149
Ashburn 146
Houston 144
Jacksonville 125
Seattle 119
Cambridge 109
Singapore 106
Santa Clara 82
Boardman 78
Padova 70
Princeton 42
Des Moines 40
Medford 40
Beijing 39
Roxbury 37
Helsinki 32
San Diego 32
Guangzhou 28
Nanjing 26
Dearborn 25
Changsha 13
Hebei 13
Nanchang 13
Pune 13
Shenyang 11
Jinan 10
Kunming 10
Hefei 9
Jiaxing 7
London 7
Milan 7
Cagliari 6
Dublin 6
Hong Kong 6
Riese Pio X 6
Norwalk 5
Shanghai 5
Falls Church 4
Los Angeles 4
Paris 4
Pesaro 4
Tianjin 4
Wuhan 4
Zhengzhou 4
Baotou 3
Haikou 3
Kharkiv 3
Ningbo 3
Phoenix 3
Rockville 3
Sofia 3
Bangkok 2
Benevento 2
Campodarsego 2
Cherasco 2
Columbus 2
Florence 2
Gubbio 2
Hangzhou 2
Hounslow 2
Incheon 2
Kilburn 2
Kirkland 2
Montesilvano Marina 2
New York 2
Novara 2
Redmond 2
Rome 2
Turin 2
Urbino 2
Amman 1
Amsterdam 1
Araihazar 1
Arezzo 1
Belgrade 1
Bellevue 1
Bergamo 1
Bologna 1
Borås 1
Budapest 1
Cascina 1
Central 1
Chicago 1
Chongqing 1
Cingoli 1
Dallas 1
Edinburgh 1
Falkenstein 1
Frankfurt am Main 1
Genoa 1
Harbin 1
Ho Chi Minh City 1
Iligan City 1
Indiana 1
Lanzhou 1
Lappeenranta 1
Totale 2.713
Nome #
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 191
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting 178
Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure 153
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 120
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 117
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. 113
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker. 101
Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming 100
Hepatic progenitor cells express SerpinB3 98
Role of microglial activation via SERPINB3 in experimental acute hepatic encephalopathy 97
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 92
SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I 87
IgM-linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease 86
Caratterizzazione di un modello di topo transgenico per SERPINB3 umana 85
Hepatic progenitor cells overexpress SERPINB3 in a mouse model of fulminant hepatitis 83
Cellule progenitrici epatiche esprimono SERPINB3b in un modello murino di epatite fulminante 82
Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice. 80
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 80
HEPATIC PROGENITOR CELLS OVEREXPRESS SERPINB3 IN A MOUSE MODEL OF FULMINANT HEPATITIS 76
Serpin B3 differently up-regulates hypoxia inducible factors -1α and -2α in hepatocellula arcinoma: Mechanisms revealing novel potential therapeutic targets 74
Sex dependent IL-6 deregulation by SERPINB3 in a transgenic mouse model 69
Modulazione dei livelli di IL-6 nella rigenerazione epatica da parte di SERPINB3 ed estrogeni. Analisi in un modello di topo transgenico 69
SERPINB3 is associated with longer survival in transgenic mice. 67
HPYPOXYA UP-REGULATES SERPINB3 IN HEPATIC CANCER CELLS: A HIF-2a ASSOCIATED EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 64
SQUAMOUS CELL CARCINOMA ANTIGEN (SCCA) ENHANCES LIVER REGENERATION AFTER PARTIAL HEPATECTOMY 64
Overexpression of SERPINB3 in hepatic progenitor cells in a mouse model of acute liver injury 62
RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA 60
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 60
RUOLO DI SERPINB3 NELLA PROGRESSIONE DELLA MALATTIA EPATICA 54
OVEREXPRESSION OF SERPINB3 IN HEPATIC PROGENITOR CELLS IN A MOUSE MODEL OF ACUTE LIVER INJURY 53
SEX DEPENDENT IL-6 DEREGULATION BY SERPINB3 IN A TRANSGENIC MOUSE MODEL 49
SERPINB3 up-regulation in hepatic cancer cells: a critical HIF-2alfa and redox dependent event in liver carcinogenesis. 49
SERPINB3 è associata a una maggior sopravvivenza in un modello di topo transgenico. 48
CELLULE PROGENITRICI EPATICHE ESPRIMONO SERPINB3 IN UN MODELLO MURINO DI EPATITE FULMINANTE 47
ROLE OF MICROGLIAL ACTIVATION VIA SERPINB3 IN EXPERIMENTAL ACUTE HEPATIC ENCEPHALOPATY 45
Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3 43
SERPIN B3 TRANSGENIC MICE ARE MORE SUSCEPTIBLE TO LUNG FIBROSIS AND EPITHELIAL PROLIFERATION 43
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation 42
Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici 38
SERPINB3 AS A PRO-INFLAMMATORY MEDIATOR IN THE PROGRESSION OF EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE. 37
HIGH BRAIN EXPRESSION OF SQUAMOUS CELL CARCINOMA ANTIGEN ENHANCES BRAIN INJURY IN A TRANSGENIC MOUSE MODEL OF ACUTE LIVER FAILURE: A PILOT STUDY 37
MODULAZIONE DEI LIVELLI DI IL-6 NELLA RIGENERAZIONE EPATICA DA PARTE DI SERPINB3 ED ESTROGENI. ANALISI IN UN MODELLO DI TOPO TRANSGENICO 35
SERPINB3 transgenic mice are more susceptible to lung fibrosis and epithelial proliferation 24
Clinical characteristics and laboratory biomarkers changes in COVID-19 patients requiring or not intensive or sub-intensive care: a comparative study 19
Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice 17
The Protease Activated Receptor 2 - CCAAT/Enhancer-Binding Protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of Non-Alcoholic Steatohepatitis 16
Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo 16
SerpinB3 as hepatic marker of post-resective shear stress 15
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition 13
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness 12
1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition 9
Totale 3.369
Categoria #
all - tutte 13.402
article - articoli 9.449
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 175
selected - selezionate 0
volume - volumi 0
Totale 23.026


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020358 0 0 0 0 0 0 92 71 67 72 34 22
2020/2021388 22 19 13 15 4 20 11 19 58 126 56 25
2021/2022427 9 53 55 35 15 27 16 38 15 11 40 113
2022/2023540 84 46 22 53 90 84 1 50 80 2 23 5
2023/2024298 7 57 52 22 14 30 19 19 6 7 25 40
2024/2025396 9 79 29 68 125 53 33 0 0 0 0 0
Totale 3.369